If your GLP-1 medication — whether semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) — was denied by insurance, you're not alone and you're not out of options. We connect you with safe, affordable, physician-supervised therapy and a support community to help you stay on track.
This isn't about you or your health — it's about insurance companies tightening the rules on medications like Ozempic, Wegovy, Mounjaro, and Zepbound. The data speaks for itself.
When insurance says no and nobody helps you navigate what's next, the odds aren't in your favor.
Most patients abandon treatment after a denial — losing momentum, regaining weight, and feeling like they've failed.
53% of patients using weight-loss meds report doing so without consulting a physician — often through social media or unlicensed sellers.
Studies consistently show most patients who stop GLP-1 therapy regain the weight — reversing hard-won clinical progress.
No fighting with your insurance. No searching the internet for questionable sources. Just a clear, safe path forward.
Fill out the form below or give us a call. We'll learn about your situation, your denial, and what you're looking for — no commitment, no pressure.
We'll introduce you to a licensed telehealth partner who can evaluate your needs and, if appropriate, prescribe safe, affordable GLP-1 therapy — whether semaglutide or tirzepatide — all under physician supervision.
You'll join a community of people on the same path — with ongoing support, education, and accountability to help you reach your metabolic health goals. And you stay connected to your primary care doctor throughout.
We've built this to give you the care, access, and support your insurance denied you.
Every prescription comes from a licensed physician who evaluates your individual health needs. This isn't a shortcut — it's real medical care.
Access GLP-1 therapy at a fraction of the branded retail cost — without needing insurance approval.
Join a community of people on the same journey — with coaching, accountability, and shared experience to help you stay on track.
We don't replace your primary care physician — we work alongside them. Your doctor stays informed and in the loop.
If your insurance denied your GLP-1 — whether it was Ozempic, Wegovy, Mounjaro, or Zepbound — you may have heard about "compounded" versions. There's a lot of misinformation out there. Here's a clear, fact-based breakdown so you can make an informed decision with your physician.
| Branded (Ozempic, Wegovy, Mounjaro, Zepbound) | Compounded GLP-1 | |
|---|---|---|
| FDA Approved | ✓ Yes | ✗ Not FDA-approved — but may be legally compounded under specific conditions |
| Active Ingredient | Semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound) — exact proprietary formulation | Semaglutide or tirzepatide base — must be sourced from FDA-registered facilities using USP-grade ingredients |
| Cost | $1,000–$1,500+/month without insurance | Typically $150–$400/month |
| Delivery | Pre-filled pen (fixed doses) | Vial + syringe (requires accurate dosing with physician guidance) |
| Oversight | Manufactured under FDA cGMP standards | 503A: state-regulated; 503B: FDA-registered and inspected |
| Prescription Required | ✓ Yes | ✓ Yes — must come from a licensed physician |
State-licensed pharmacy — Your medication should come from a pharmacy licensed by a state board of pharmacy, not a "wellness clinic" or med spa.
503A or 503B designation — 503A pharmacies compound patient-specific prescriptions. 503B outsourcing facilities are FDA-registered and inspected.
Valid physician prescription — A licensed healthcare provider must evaluate you and write the prescription. No legitimate pharmacy will sell without one.
Correct active ingredient form — The FDA has warned that salt forms (like semaglutide sodium or acetate) have not been evaluated for safety. Ensure your pharmacy uses semaglutide base or tirzepatide base.
Clear dosing instructions — Your provider should give you specific dosing in milligrams with a titration schedule — not vague "unit" measurements. This applies to both semaglutide and tirzepatide.
Third-party testing — Reputable pharmacies provide potency and sterility testing results for each batch. Ask for a Certificate of Analysis (COA).
No prescription required — If a company sells semaglutide or tirzepatide without a physician evaluation, walk away. This is illegal and unsafe.
Labeled "for research only" — Products marketed as research chemicals or "not for human consumption" are not safe for injection.
Claims of being "generic Ozempic" or "generic Mounjaro" — There are no FDA-approved generics of these medications. Any such claim is false and misleading.
Sold through social media or unlicensed sellers — The FDA has documented counterfeit GLP-1s with wrong ingredients, wrong doses, or no active ingredient at all.
Our telehealth partner works only with licensed, regulated pharmacies and provides physician-supervised dosing for both semaglutide and tirzepatide — so you get the affordability of compounding with the safety of real medical oversight.
Learn How to Get Started →Yes. You'll be evaluated by a licensed physician who reviews your medical history and determines if GLP-1 therapy is appropriate for you. Your medication — whether semaglutide or tirzepatide — comes from a licensed, regulated pharmacy, not an unvetted online source. And your primary care doctor can stay informed throughout.
Costs vary depending on medication and dosage, but patients typically pay between $150–$400 per month — a fraction of the $1,000–$1,500+/month retail price of branded GLP-1s like Ozempic, Wegovy, Mounjaro, or Zepbound. No insurance needed.
Yes. Our telehealth partner will conduct their own evaluation and, if appropriate, write you a prescription for either semaglutide or tirzepatide based on your individual needs. This ensures the medication and dose are right for your current health status.
We encourage full transparency with your primary care physician. You can share your treatment details with your doctor at any time, and we're happy to coordinate with their office to keep continuity of care intact.
Both are GLP-1 receptor agonists used for weight management and blood sugar control. Semaglutide (the active ingredient in Ozempic and Wegovy) targets GLP-1 receptors. Tirzepatide (the active ingredient in Mounjaro and Zepbound) is a dual-action medication that targets both GLP-1 and GIP receptors. Your telehealth physician will help determine which is the better fit for your health profile and goals.
Not exactly. Compounded versions contain the same active ingredient but are prepared by a compounding pharmacy, not the brand manufacturer. They are not FDA-approved and may differ in inactive ingredients or delivery format (vials vs. pre-filled pens). They should only be used when prescribed by a licensed physician and sourced from a regulated pharmacy. Our telehealth partner ensures proper sourcing, dosing, and oversight.
Absolutely. If your insurance situation changes or branded options become more accessible, transitioning back is straightforward with your physician's guidance. Our goal is to keep you on a safe, effective path — not lock you into one option.
In many cases, yes — but it should always be done under physician supervision. The dosing, titration schedules, and side effect profiles are different between the two medications. Your telehealth physician can guide you through a safe transition if switching makes sense for your treatment plan.
You'll have access to a community of other patients on a similar journey — with resources, accountability, and shared experience. This helps with motivation, questions, and the day-to-day realities of metabolic health management.
Fill out the form and we'll reach out to walk you through your options — or contact us directly. No pressure, no commitment. Just answers.
We'll get back to you within one business day.
We'll reach out within one business day to walk you through your options. You're not alone in this.